Skip to content

Clinical trials

Phase 1 Fibrosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Phase: Phase 1 Country / region: United States Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20072
20081
20092
20102
20121
20131
20142
20153
20163
20172
20184
20192
20201
20213
20223
20232
20243
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Recruiting6
Terminated5
Unknown status5
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
M.D. Anderson Cancer Center2
National Cancer Institute (NCI)2
Virginia Commonwealth University2
Abramson Cancer Center at Penn Medicine1
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)1
AstraZeneca1
Genzyme, a Sanofi Company1
Gilead Sciences1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis43
Carcinoma, Hepatocellular5
Liver Cirrhosis5
Cicatrix3
Hepatic Encephalopathy3
Idiopathic Pulmonary Fibrosis3
Ascites2
Cholangitis, Sclerosing2
Hepatitis B2
Hepatitis C2

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.